✦ LIBER ✦

Safety of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of efalizumab for the treatment

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and safety of efalizumab for sc

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy and safety of efalizumab in adu

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Control of Moderate-to-Severe Plaque Pso

✍ Fernando M. Stengel; Valeria Petri; Gladys A.M. Campbell; Gladys Leon Dorantes; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Efficacy and Safety of Efalizumab in Pat

✍ Torello Lotti; Sergio Chimenti; Andreas Katsambas; Jean-Paul Ortonne; Louis Dube 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

Safety and tolerability of efalizumab th

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB